MedTrace Logo

Global Healthcare Study on Atopic Dermatitis

NCT07659756 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9600

Last updated 2026-06-22

No results posted yet for this study

Summary

The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.

Conditions

  • Atopic Dermatitis (AD)
  • Atopic Dermatitis (Eczema)

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • University Hospital, Zürich

    collaborator OTHER

  • Julia Tatjana Maul

    lead OTHER

Principal Investigators

  • Julia-Tatjana Maul, Prof. Dr. med. · University of Zurich

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07659756 on ClinicalTrials.gov